MedPath
NMPA Approval

Trastuzumab Injection

J20170037

May 11, 2017

Drug Information

注射用曲妥珠单抗

赫赛汀

注射剂

440 mg(20 ml)/瓶

生物制品

May 11, 2017

Company Information

Applicant Company

GENENTECH INC

Schoenmattstrasse 2, 4153 Reinach

Manufacturing Company

GENENTECH INC

South San Francisco, CA 94080

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用曲妥珠单抗 - NMPA 批准文号 | MedPath